Name: bioAffinity Technologies, Inc. (BIAF) Financial Statements
Creator: FinSpry

bioAffinity Technologies Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

bioAffinity Technologies, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	9.36	2.53	0.00	0.00	0.00
Cost of Revenue	5.98	1.74	0.00	0.00	0.00
Gross Profit	3.38	0.79	0.00	0.00	0.00
Operating Expenses
Research & Development	1.78	1.72	1.52	1.14	1.61
Selling, General & Administrative	9.94	6.79	2.48	1.07	0.99
Operating Expenses	12.33	8.76	4.02	2.21	2.60
Operating Income	-8.95	-7.97	-4.01	-2.21	-2.60
Other Income/Expense
Interest Income	0.02	0.12	0.05	0.00	0.00
Interest Expense	0.09	-0.04	2.53	-1.00	-0.38
Other Income/Expense	-0.08	-0.03	-1.65	-3.36	0.00
Income
Income Before Tax	-9.03	-7.92	-8.15	-6.32	-7.27
Income Tax Expense	0.01	0.02	0.00	0.00	0.00
Net Income	-9.04	-7.94	-8.15	-6.33	-7.27
Net Income - Continuous Operations	-9.04	-7.94	-8.15	-6.33	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-8.33	-7.72	-5.61	-2.20	-2.58
EBIT	-8.95	-7.97	-5.62	-2.21	-2.60
Depreciation & Amortization	0.61	0.25	0.01	0.00	0.02
Earnings Per Share
Basic EPS	-22.00	-27.00	-54.00	-71.00	-82.00
Diluted EPS	-22.00	-27.00	-54.00	-71.00	-82.00
Basic Shares Outstanding	0.40	0.29	0.15	0.09	0.09
Diluted Shares Outstanding	0.40	0.29	0.15	0.09	0.09